Amgen Inc. v. Sanofi, Aventisub LLC

 
APPEAL NO.
20-1074
OP. BELOW
DCT
OPINION
TBD
SUBJECT
Patent
AUTHOR
TBD

Issue(s) Presented

“Whether the district court erred in holding that any reasonable juror was required to find that Sanofi-Regeneron established non-enablement by clear-and- convincing evidence.”

Posts About this Case